Paper884693
Role of drug concentration, duration of exposure, and endogenous metabolites in determining methotrexate cytotoxicity.
Pinedo HM and 1 other. Cancer Treat Rep, 1977. Cited by 90 papers, by iCite.
Cite this record
ConductScience Library. Role of drug concentration, duration of exposure, and endogenous metabolites in determining methotrexate cytotoxicity. Papers, record 884693. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/884693
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Role of drug concentration, duration of exposure, and endogenous metabolites in determining methotrexate cytotoxicity.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Survival | Major topic |
| Methotrexate | Major topic |
| Animals | |
| Bone Marrow | |
| Bone Marrow Cells | |
| Cell Division | |
| Cells, Cultured | |
| DNA | |
| Folic Acid | |
| Humans | |
| In Vitro Techniques | |
| Osmolar Concentration | |
| Purine Nucleosides | |
| Time Factors |
Source PubMed
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 90 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41824102 | Role of cystatin C in predicting the risk of hypermethotrexemia and kidney injury after high-dose methotrexate chemotherapy in childhood acute lymphoblastic leukemia. | Ann Hematol | 2026 | https://conductscience.org/library/papers/41824102 | PubMed |
| 41114001 | An In Vitro Platform for Pharmacokinetic Quantification and Optimization of Cerebrospinal Fluid Filtration and Drug Circulation. | J Med Device | 2025 | https://conductscience.org/library/papers/41114001 | PubMed |
| 40454410 | Cerebrospinal fluid attenuates the efficacy of methotrexate against acute lymphoblastic leukemia cells. | Blood Neoplasia | 2025 | https://conductscience.org/library/papers/40454410 | PubMed |
| 40258971 | An atlas of transcriptomic changes in human immune cells driven by 364 endogenous and gut-microbiota-derived metabolites. | Sci Rep | 2025 | https://conductscience.org/library/papers/40258971 | PubMed |
| 39527259 | Periprosthetic seromas and a third space effect after high-dose methotrexate. | Wien Klin Wochenschr | 2025 | https://conductscience.org/library/papers/39527259 | PubMed |
| 36688106 | Target concentration achievement for efficacy and safety of patients with osteosarcoma treated with high-dose methotrexate based on individual pharmacokinetics: A retrospective study. | Oncol Lett | 2023 | https://conductscience.org/library/papers/36688106 | PubMed |
| 34378331 | Prospective evaluation of high-dose methotrexate pharmacokinetics in adult patients with lymphoma using novel determinants of kidney function. | Clin Transl Sci | 2022 | https://conductscience.org/library/papers/34378331 | PubMed |
| 31657864 | Pharmacokinetic basis for dosing high-dose methotrexate in infants and young children with malignant brain tumours. | Br J Clin Pharmacol | 2020 | https://conductscience.org/library/papers/31657864 | PubMed |
| 29780646 | Incorporating Cystatin C to Predict Methotrexate Elimination in Patients with CNS Lymphoma and Suspicious Renal Function. | Case Rep Hematol | 2018 | https://conductscience.org/library/papers/29780646 | PubMed |
| 21444869 | Shortening infusion time for high-dose methotrexate alters antileukemic effects: a randomized prospective clinical trial. | J Clin Oncol | 2011 | https://conductscience.org/library/papers/21444869 | PubMed |
| 16990760 | High leucovorin doses during high-dose methotrexate treatment may reduce the cure rate in childhood acute lymphoblastic leukemia. | Leukemia | 2006 | https://conductscience.org/library/papers/16990760 | PubMed |
| 15634030 | Pharmacokinetics following intraventricular administration of chemotherapy in patients with neoplastic meningitis. | Clin Pharmacokinet | 2005 | https://conductscience.org/library/papers/15634030 | PubMed |
| 7160050 | High-dose methotrexate: a clinical and pharmacokinetic evaluation. Treatment of advanced squamous cell carcinoma of the head and neck using a prospective mathematical model and pharmacokinetic surveillance. | Cancer Chemother Pharmacol | 1982 | https://conductscience.org/library/papers/7160050 | PubMed |
| 6970753 | Long-duration intracavitary infusion of methotrexate with systemic leucovorin protection in patients with malignant effusions. | J Clin Invest | 1981 | https://conductscience.org/library/papers/6970753 | PubMed |
| 6585345 | Synchronization of human leukemic cells: relevance for high-resolution chromosome banding. | Hum Genet | 1984 | https://conductscience.org/library/papers/6585345 | PubMed |
| 3839754 | Clinical pharmacokinetics of 6-hour infusion of high-dose methotrexate. Preliminary trial of monitoring high infusion doses. | Eur J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/3839754 | PubMed |
| 3733857 | Role of culture conditions and exposure duration in determining sensitivity of human bone marrow progenitor cells to methotrexate. | J Cancer Res Clin Oncol | 1986 | https://conductscience.org/library/papers/3733857 | PubMed |
| 3555940 | Pharmacokinetics of anticancer drugs in children. | Clin Pharmacokinet | 1987 | https://conductscience.org/library/papers/3555940 | PubMed |
| 3311530 | Therapeutic drug monitoring in oncology. Problems and potential in antineoplastic therapy. | Clin Pharmacokinet | 1987 | https://conductscience.org/library/papers/3311530 | PubMed |
| 3260832 | Methotrexate administered by 6-h and 24-h infusion: a pharmacokinetic comparison. | Cancer Chemother Pharmacol | 1988 | https://conductscience.org/library/papers/3260832 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/884693
GET https://conductscience.org/api/papers/v1/884693/cited_by?page=2